Your account is not claimed yet. You can sign up with ORCID to claim your account.

Michael D Wyatt

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

University of South Carolina

University College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of South Carolina

United States

Professor of Biomedicinal Chemistry :: Drug Discovery and Biomedical Sciences

Education History

University College London

United Kingdom

PHD :: Oncology

Publications

B Celia Cui, Marina Aksenova, Aliaksandra Sikirzhytskaya, Diana Odhiambo, Elizaveta Korunova, Vitali Sikirzhytski, Hao Ji, Diego Altomare, Eugenia V Broude, Norma Frizzell, Rosemarie M Booze, Michael D Wyatt, Michael S Shtutman
Suppression of HIV and cocaine-induced neurotoxicity and inflammation by cell penetrable itaconate esters. bioRxiv : the preprint server for biology (2023)
Danda Chapagai, George Merhej, Campbell McInnes, Michael D Wyatt
Structural Basis for Variations in Polo-like Kinase 1 Conformation and Intracellular Stability Induced by ATP-Competitive and Novel Noncompetitive Abbapolin Inhibitors. ACS chemical biology (2023)
Megha Jhanji, Chintada Nageswara Rao, Jacob C Massey, Marion C Hope, Xueyan Zhou, C Dirk Keene, Tao Ma, Michael D Wyatt, Jason A Stewart, Mathew Sajish
Cis- and trans-resveratrol have opposite effects on histone serine-ADP-ribosylation and tyrosine induced neurodegeneration. Nature communications 13 (1) (2022)
Danda Chapagai, Gurusankar Ramamoorthy, Jessy Varghese, Elmar Nurmemmedov, Campbell McInnes, Michael D Wyatt
Nonpeptidic, Polo-Box Domain-Targeted Inhibitors of PLK1 Block Kinase Activity, Induce Its Degradation and Target-Resistant Cells. Journal of medicinal chemistry 64 (14) (2021)
Merissa Baxter, Danda Chapagai, Sandra Craig, Cecilia Hurtado, Jessy Varghese, Elmar Nurmemmedov, Michael D Wyatt, Campbell McInnes
Peptidomimetic Polo-Box-Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor. ChemMedChem 15 (12) (2020)
Chloé E LeBegue, Bryan L Love, Michael D Wyatt
Microbes as Drugs: The Potential of Pharmabiotics. Pharmacotherapy 40 (2) (2020)
Adewale Adeluyi, Lindsey Guerin, Miranda L Fisher, Ashley Galloway, Robert D Cole, Sherine S L Chan, Michael D Wyatt, Shannon W Davis, Linnea Ruth Freeman, Pavel I Ortinski, Jill R Turner
Microglia morphology and proinflammatory signaling in the nucleus accumbens during nicotine withdrawal. Science advances 5 (10) (2019)
Michael D Wyatt, Nicole M Reilly, Shikha Patel, Preeti Rajesh, Gary P Schools, Phillip G Smiraldo, Douglas L Pittman
Thiopurine-induced mitotic catastrophe in Rad51d-deficient mammalian cells. Environmental and molecular mutagenesis 59 (1) (2017)

Michael D Wyatt.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michael D Wyatt